JOING FILING AGREEMENTJoing Filing Agreement • September 6th, 2019 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Idera Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
JOING FILING AGREEMENTJoing Filing Agreement • February 14th, 2001 • Kluge John W • Telephone communications (no radiotelephone)
Pursuant to Rule 13d-1(f)(i)(iii) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Statement to which this Exhibit is attached is filed on behalf of each of them.
JOING FILING AGREEMENTJoing Filing Agreement • September 25th, 2008 • Greenberg Maurice R • Fire, marine & casualty insurance
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of American International Group, Inc., and that this Agreeement be included as an Exhibit to such joint filing.
JOING FILING AGREEMENTJoing Filing Agreement • January 10th, 2017 • Baker Bros. Advisors Lp • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Achaogen, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
JOING FILING AGREEMENTJoing Filing Agreement • February 16th, 2016 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Idera Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
